134 related articles for article (PubMed ID: 11558535)
1. Experimental chemotherapy against canine mammary cancer xenograft in SCID mice and its prediction of clinical effect.
Yamashita A; Maruo K; Suzuki K; Shirota K; Kobayashi K; Hioki K
J Vet Med Sci; 2001 Aug; 63(8):831-6. PubMed ID: 11558535
[TBL] [Abstract][Full Text] [Related]
2. Schedule-dependent potentiation of chemotherapeutic drugs by the bioreductive compounds NLCQ-1 and tirapazamine against EMT6 tumors in mice.
Papadopoulou MV; Ji M; Bloomer WD
Cancer Chemother Pharmacol; 2001 Aug; 48(2):160-8. PubMed ID: 11561782
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy of ovarian cancer based on in vitro (HTCA) and in vivo (nude mice) chemosensitivity testing].
Sagawa T; Yamashita K; Kawamura M; Shimizu T; Haga H; Yorozu Y; Kasamo M; Fujita M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1197-204. PubMed ID: 2411831
[TBL] [Abstract][Full Text] [Related]
4. Schedule-dependent interaction between vinblastine and cisplatin in Ehrlich ascites tumors in mice.
Cemazar M; Auersperg M; Scancar J; Kirbis IS; Pogacnik A; Sersa G
J Pharmacol Exp Ther; 2002 Jul; 302(1):337-43. PubMed ID: 12065735
[TBL] [Abstract][Full Text] [Related]
5. [Non-cross-resistant sequential combination chemotherapy consisting of cis-diammine-dichloroplatinum (II) mainly, based on synchronization theory, in human bladder cancer xenografts in athymic nude mice].
Yamauchi T; Okada K; Yoshida O
Hinyokika Kiyo; 1986 Dec; 32(12):1781-97. PubMed ID: 2435129
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy of carcinoma of the prostate and testis: experimental study in vivo and in vitro].
Okada K; Kanamaru H; Yoshiki T; Hashimura T; Nishimura K; Hida S; Nishio Y; Oishi K; Yoshida O; Yamauchi T
Hinyokika Kiyo; 1988 Nov; 34(11):1911-6. PubMed ID: 2468265
[TBL] [Abstract][Full Text] [Related]
7. Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ.
Grau C; Overgaard J
Cancer Chemother Pharmacol; 1992; 30(4):277-80. PubMed ID: 1643695
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
[TBL] [Abstract][Full Text] [Related]
9. The role of additional chemotherapy with oral UFT in intravenous combination chemotherapy with cisplatin and 5-fluorouracil for human gastric cancer xenograft lines of well- and poorly- differentiated adenocarcinomas transplanted in nude mice.
Tseng CC; Nio Y; Tsubono M; Kawabata K; Masai Y; Hayashi H; Fukumoto M; Tobe T
Anticancer Res; 1992; 12(4):1295-9. PubMed ID: 1503424
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784
[TBL] [Abstract][Full Text] [Related]
11. Levels of viral glycoprotein reflect enhanced effectiveness of combined drug treatments.
Ritzi EM; Pyo S
Life Sci; 1994; 54(13):887-99. PubMed ID: 8139377
[TBL] [Abstract][Full Text] [Related]
12. Antitumor efficacy of nedaplatin, a novel platinum complex, with cyclophosphamide in murine and human tumor model.
Uchida N; Takeda Y; Kasai H; Maekawa R; Sugita K; Yoshioka T
Anticancer Res; 1998; 18(5A):3375-9. PubMed ID: 9858911
[TBL] [Abstract][Full Text] [Related]
13. [Combined effect of PT-050 (recombinant human TNF) and antitumor drugs on syngeneic murine tumors].
Nakata K; Yoshida H; Kashimoto S; Sohmura Y; Nakamura S; Taguchi T
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3186-93. PubMed ID: 3096217
[TBL] [Abstract][Full Text] [Related]
14. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
[TBL] [Abstract][Full Text] [Related]
15. In vitro efficacy of chemotherapeutics as determined by 50% inhibitory concentrations in cell cultures of mammary gland tumors obtained from dogs.
Simon D; Knebel JW; Baumgartner W; Aufderheide M; Meyer-Lindenberg A; Nolte I
Am J Vet Res; 2001 Nov; 62(11):1825-30. PubMed ID: 11703031
[TBL] [Abstract][Full Text] [Related]
16. Schedule-dependent and -independent antitumor activity of paclitaxel-based combination chemotherapy against M-109 murine lung carcinoma in vivo.
Fujimoto S; Chikazawa H
Jpn J Cancer Res; 1998 Dec; 89(12):1343-51. PubMed ID: 10081496
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapeutic treatment of xenograft Spirocerca lupi-associated sarcoma in a murine model.
Stettner N; Ranen E; Dank G; Lavy E; Brenner O; Harmelin A
Comp Med; 2007 Jun; 57(3):267-71. PubMed ID: 17605341
[TBL] [Abstract][Full Text] [Related]
18. [Experimental study of CF chemotherapy, combined with another one chemotherapeutic drug against head and neck cancer cell lines].
Tsukuda M; Mochimatsu I; Kokatsu T; Ito K; Furukawa S; Inoue T; Watanabe S; Sawaki S
Gan To Kagaku Ryoho; 1992 Apr; 19(4):553-6. PubMed ID: 1373052
[No Abstract] [Full Text] [Related]
19. Antitumor activity of menogaril alone, and in combination against human mammary cancer models in mice and rats.
Yoshida M; Fujioka A; Nakano K; Kobunai T; Saito H; Toko T; Takeda S; Unemi N
Anticancer Res; 1996; 16(3A):1155-9. PubMed ID: 8702227
[TBL] [Abstract][Full Text] [Related]
20. [Fundamental study of combination chemotherapy with THP, 5-FU and CDDP for human KB carcinoma cell line and its multidrug resistant cell line KB-C1--usefulness of treatment with 5-FU preceding CDDP].
Kishimoto H; Manno Y; Tanaka H; Moridera K; Urade M
Gan To Kagaku Ryoho; 2001 Apr; 28(4):505-9. PubMed ID: 11329785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]